How do you figure? Burn rate of 10m plus a quarter . Not short ,never short,in fact made money long on the last run after the RS. No revs from sales?. Macrilen what 30m at best? And at what cost to generate ? It's all about Zoptrex and we know how long these cancer drugs and FDA take assuming the results are good
Plenty of cash to bring both to market is not true,they'll be out by this time next year.. Macrilen could bring in 35 mil after years of marketing in rev NOT profit and not enough to sustain the company .
Zoptrex if successful .. they won't make ihence the December filing for more dilution
Ya know disco. I still don't get why you've hated this company and bashed for years BUT...
One thing you spoke of before..how can the company be incurring the selling expenses and staff for products they've now had on market for a while and have nothing...absolutely nothing to show??
And the Zoptrex study..? Blinded? Except for a partners comments about its potential.
Macrilen? If it gets thru the potential revs won't even keep the company break even..
Still think Zoptrex could be real but geeeeeesh